Search

everythinglearnresearchcommunity

for

Search:↓

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

A woman with type 2 diabetes developed alopecia areata, suggesting a link between the two autoimmune conditions.

The model and estimator can predict drug exposure in kidney transplant patients well.

Growth factors influence hair growth and hair loss.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Possible link between COVID-19 and hair loss; more research needed.

Eclipta alba shows promise for medicinal use but needs more research.

Doctors disagree on whether Raynaud phenomenon often leads to serious diseases, but agree that patients should be monitored for possible progression while being reassured. Rapid weight loss may cause hair loss.

p63 is essential for controlling epithelial stem cells and tissue health.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Different types of stem cells with unique roles exist in blood, skin, and intestines, and this variety is important for tissue repair.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Targeting colon cancer stem cells might lead to better treatment results.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Hair loss in men is common, treatable, but not curable.